Planet Labs PBC (PL)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-31
Reading PL? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-31
Reading PL? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue growth is accelerating — up about 34% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 38%, softest on share dilution.
View QualityManagement screens weak on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 62% in its worst 12-month stretch.
View RiskPlanet Labs (PL) aims to grow revenue through strategic agreements in the space data market. Recent revenue growth was 42% year over year, and the last quarter met expectations. PL trades at 21× price-to-sales, which is above the peer median of 3.5×. This suggests that the price reflects less growth than expected. A specific risk is that PL may cut guidance on the next call, with a 20% chance of missing estimates. Peer multiples imply a price about 3% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. PL is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering PL (as of Jul 2026).
Based on 6 Wall Street analysts offering 12-month price targets for PL in the last 4 months.
A consensus fair price across our valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No fair value published
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
This applies to all three horizons. The trailing multiples, peer comparison, and quality and trajectory reads on this page are unaffected. Names move in and out of this state day to day as the methods converge or diverge. Method agreement on this name is low.
Bottom 25% on quality vs scored peers
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
CEO stock sale raises concerns about leadership stability.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $20.48
The last 12 months of price, then the range of analyst 12-month targets from today’s $20.48.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.

Advances: Expand revenue through strategic agreements
Significant deal enhances revenue growth potential.
Advances: Expand revenue through strategic agreements
Building higher-value data story aligns with revenue expansion.
Threatens: Achieve positive operating income
ATM offering threatens positive operating income objective.
Advances: Expand revenue through strategic agreements
Record revenue and government contracts align with growth objective.